FAS and neoplasm: Thus it is possible that 5-FU can prime tumor cells for immune attack by altering expression of key surface proteins, such as Fas and possibly others (e.g. Trail and MHC class I), and in this way contribute to enhancing Ad5-OVA anti-tumor immunity.